Clinical Research PR, Inc.

San Juan 75246

0 studies enrolling now · 4 studies all time

What they study most

HIV, HIV Infections, HIV-1-infection

Studies at this site

• Dose Escalation Safety Study of TMB-365 in HIV-1 Infected Participants — Completed
• Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1 — Completed
• Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV — Completed
• Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients — Completed